• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB

DIMERIX LIMITED - Charts / Financials

3.92% ! 49.0¢
Market Cap $294.0M  !
Healthcare Biotechnology
Add to My Watchlist

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 09/09/2025 (20 minute delay) ?
Day
Open 51.0¢   Day High 51.0¢   Day Low 48.0¢
Daily Volume 821507
Bids   Sellers
Number Price Volume   Number Price Volume
1 48.5¢ 2063   2 49.0¢ 19719

Directors & Senior Management

Dr. Nina Webster Chief Executive Officer, Managing Director, Director
Mr. Hamish George Chief Financial Officer, Company Secretary
Dr. David Fuller Chief Medical Officer
Dr. Ash Soman Member of the Executive Board
Mr. Mark Diamond Non-Executive Chairman of the Board
Mr. Hugh Alsop Non-Executive Director
Dr. Sonia Maria Poli Non-Executive Director
Mr. Clinton Snow Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
49.0¢ 		Change
-0.020(3.92%) 		Mkt cap ! $294.0M
Open High Low Value Volume
51.0¢ 51.0¢ 48.0¢ $404.4K 821.5K

Buyers (Bids)

No. Vol. Price($)
1 2063 48.5¢
 

Sellers (Offers)

Price($) Vol. No.
49.0¢ 19719 2
View Market Depth
Last trade - 16.10pm 09/09/2025 (20 minute delay) ?
Last
49.0¢ 		  Change
-0.020 ( 3.14 %)
Open High Low Volume
50.5¢ 50.5¢ 48.0¢ 324665
Last updated 15.59pm 09/09/2025 ?

Top Stories

Nanocap Livium pops +30% on purchase of REE extraction technology from Melb Uni

Livium has become one of the nanocaps juicing hard, with shares up nearly +30% as the company inks a deal alongside Melbourne University.
Market Close: 4DX Medical finally pulls back; war makes ESG investing cool again Good Afternoon and welcome to HotCopper’s Market Close for Tuesday 9th of September, I’m Jon Davidson. The ASX200 retreated back to the 8,700s intraday as Wall Street finished flattish green overnight leaving little to imagine in terms of bullish sentiment; as of 3...
It's a penny stock buyer's market. Adelong Gold jumps +20% as Nova Mins buys in Adelong Gold, a nanocap and pennystock, jumped +20% in mid-arvo trades after Nova Minerals, also listed on the Nasdaq, bought a 9.4% stake.
Talga back to 50cps on news it's cracked US battery market – with metals recycling shine Shareholders in sometimes troubled graphite player Talga Group have rewarded the company's acumen to move into the U.S. battery anode market.
Listen: HotCopper Wire Podcast 023 – Glowing gold, shining silver, and... wheat collusion? In this HotCopper Wire episode, we look at surging gold and silver as well as Trump's appeals court clash, and a wheat futures conspiracy.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.